Literature DB >> 22619224

Autologous hematopoietic stem cell transplantation for multiple sclerosis--if confused or hesitant, remember: 'treat with standard immune suppressive drugs and if no inflammation, no response'.

Richard K Burt, Roumen Balabanov, Julio Voltarelli, Amilton Barreira, Joachim Burman.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22619224     DOI： 10.1177/1352458512442993

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  10 in total

1.  Autologous hematopoietic stem cell transplantation following pulsed cyclophosphamide in a severely disabled patient with malignant multiple sclerosis.

Authors:  James J P Alix; Daniel J Blackburn; Dilraj Sokhi; Ian Craven; Basil Sharrack; John A Snowden
Journal:  J Neurol       Date:  2012-12-27       Impact factor: 4.849

2.  Defective expression of apoptosis-related molecules in multiple sclerosis patients is normalized early after autologous haematopoietic stem cell transplantation.

Authors:  G L V de Oliveira; A F Ferreira; E P L Gasparotto; S Kashima; D T Covas; C T Guerreiro; D G Brum; A A Barreira; J C Voltarelli; B P Simões; M C Oliveira; F A de Castro; K C R Malmegrim
Journal:  Clin Exp Immunol       Date:  2016-12-23       Impact factor: 4.330

3.  Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases.

Authors:  John A Snowden; Manuela Badoglio; Myriam Labopin; Sebastian Giebel; Eoin McGrath; Zora Marjanovic; Joachim Burman; John Moore; Montserrat Rovira; Nico M Wulffraat; Majid Kazmi; Raffaella Greco; Emilian Snarski; Tomas Kozak; Kirill Kirgizov; Tobias Alexander; Peter Bader; Riccardo Saccardi; Dominique Farge
Journal:  Blood Adv       Date:  2017-12-20

Review 4.  Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Authors:  Tobias Alexander; Raffaella Greco
Journal:  Bone Marrow Transplant       Date:  2022-05-16       Impact factor: 5.174

5.  Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis.

Authors:  Nikolai Pfender; Riccardo Saccardi; Roland Martin
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

Review 6.  Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis.

Authors:  Laura E Baldassari; Robert J Fox
Journal:  Drugs       Date:  2018-10       Impact factor: 11.431

Review 7.  Emerging Cellular and Molecular Strategies for Enhancing Central Nervous System (CNS) Remyelination.

Authors:  Mohammad Abu-Rub; Robert H Miller
Journal:  Brain Sci       Date:  2018-06-15

8.  Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis.

Authors:  Richard K Burt; Xiaoqiang Han; Kathleen Quigley; Irene B Helenowski; Roumen Balabanov
Journal:  J Neurol       Date:  2021-10-11       Impact factor: 6.682

Review 9.  Cell-based therapeutic strategies for multiple sclerosis.

Authors:  Neil J Scolding; Marcelo Pasquini; Stephen C Reingold; Jeffrey A Cohen
Journal:  Brain       Date:  2017-11-01       Impact factor: 13.501

Review 10.  Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives.

Authors:  Mohammad Mominur Rahman; Mohammad Rezaul Islam; Mohammad Touhidul Islam; Mohammad Harun-Or-Rashid; Mahfuzul Islam; Sabirin Abdullah; Mohammad Borhan Uddin; Sumit Das; Mohammad Saidur Rahaman; Muniruddin Ahmed; Fahad A Alhumaydhi; Talha Bin Emran; Amany Abdel-Rahman Mohamed; Mohammad Rashed Iqbal Faruque; Mayeen Uddin Khandaker; Gomaa Mostafa-Hedeab
Journal:  Biology (Basel)       Date:  2022-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.